Smad1 Expression in Follicular Lymphoma
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Follicular lymphomas present with various immunohistologic patterns. The immunohistochemical markers used in the diagnosis of follicular lymphoma show variable degrees of sensitivity and specificity, and thus, additional germinal center markers are required. Smad1 has been reported to be overexpressed in follicular lymphoma, but little is known regarding the expression patterns of Smad proteins in human lymphoid tissue. Methods: In the present study, we performed immunohistochemistry for traditional germinal center markers and for Smad1 in human reactive lymphoid and follicular lymphoma tissues to investigate Smad1’s usefulness in the diagnosis of follicular lymphoma. Results: In the reactive germinal centers, most cells were positive for Smad1. Among the 27 follicular lymphoma cases, 17 of 21 (80%) were Smad1 positive, 17 of 27 (63%) were positive for CD10, and 23 of 27 (85%) were positive for Bcl6. Notably, three cases expressed CD10 only, and one only expressed Bcl6. All these cases were grade 3 tumors and showed follicular and diffuse growth patterns. Conclusions: These results indicate that Smad1 is a candidate as a germinal center marker. Furthermore, they suggest that the Smad signaling pathway might be involved in follicular lymphoma.
Abstract
Background: Follicular lymphomas present with various immunohistologic patterns. The immunohistochemical markers used in the diagnosis of follicular lymphoma show variable degrees of sensitivity and specificity, and thus, additional germinal center markers are required. Smad1 has been reported to be overexpressed in follicular lymphoma, but little is known regarding the expression patterns of Smad proteins in human lymphoid tissue. Methods: In the present study, we performed immunohistochemistry for traditional germinal center markers and for Smad1 in human reactive lymphoid and follicular lymphoma tissues to investigate Smad1’s usefulness in the diagnosis of follicular lymphoma. Results: In the reactive germinal centers, most cells were positive for Smad1. Among the 27 follicular lymphoma cases, 17 of 21 (80%) were Smad1 positive, 17 of 27 (63%) were positive for CD10, and 23 of 27 (85%) were positive for Bcl6. Notably, three cases expressed CD10 only, and one only expressed Bcl6. All these cases were grade 3 tumors and showed follicular and diffuse growth patterns. Conclusions: These results indicate that Smad1 is a candidate as a germinal center marker. Furthermore, they suggest that the Smad signaling pathway might be involved in follicular lymphoma.
참고문헌 (17)
- Younes SF, "Immunoarchitectural patterns in follicular lymphoma : efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components", Am J Surg Pathol, 34, pp.1266~1276 (2010)
- Kwon MS, "Critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the stomach and small intestine", Am J Surg Pathol, 27, pp.790~798 (2003)
- King BE, "Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas", Mod Pathol, 13, pp.1219~1231 (2000)
- Borovecki A, "Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3", Croat Med J, 49, pp.625~635 (2008)
- Ree HJ, "Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma", Hum Pathol, 32, pp.954~962 (2001)
- Husson H, "Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays", Blood, 99, pp.282~289 (2002)
- Harris NL, "WHO classification of tumors of haematopoietic and lymphoid tissues", pp.220~226 (2008), IARC Press
- Straka C, "Bcl-2gene rearrangements in primary B-cell lymphoma of the gastrointestinal tract reveal follicular lymphoma as a subtype", Leukemia, 7, pp.268~273 (1993)
- Alizadeh AA, "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature, 403, pp.503~511 (2000)
- Eshoa C, "Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas", Am J Clin Pathol, 115, pp.862~867 (2001)
- Goteri G, "BCL6 and human germinal center-associated lymphoma(HGAL)in follicular lymphomas", Diagn Pathol, 6, pp.97~ (2011)
- Yue J, "Cross-talk between the Smad1 and Ras", MEK signaling pathways for TGFbeta, 1999, pp.18, 2033~2037
- Kretzschmar M, "The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase", Genes Dev, 11, pp.984~995 (1997)
- Flanders KC, "Immunohistochemical expression of Smads 1-6 in the 15-day gestation mouse embryo : signaling by BMPs and TGF-betas", Dev Dyn, 220, pp.141~154 (2001)
- Schiemann WP, "A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma", Blood, 94, pp.2854~2861 (1999)
- Munoz O, "TGFbeta-mediated activation of Smad1 in B-cell non-Hodgkin’s lymphoma and effect on cell proliferation", Leukemia, 18, pp.2015~2025 (2004)
- 고재향, "B형 미만성 대세포 림프종에서 Smad 단백의 발현", Journal of Pathology and Translational Medicine, 38(5), pp.301~305 (2004), 대한병리학회